145 related articles for article (PubMed ID: 25134891)
1. Measuring impact on filarial infection status in a community study: role of coverage of mass drug administration (MDA).
Kumar A; Sachan P
Trop Biomed; 2014 Jun; 31(2):225-9. PubMed ID: 25134891
[TBL] [Abstract][Full Text] [Related]
2. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
Ranganath BG
J Vector Borne Dis; 2010 Mar; 47(1):61-4. PubMed ID: 20231778
[No Abstract] [Full Text] [Related]
3. A study to compare the effect of adding 12 days DEC regimen to 6 years annual mass drug administration to eliminate microfilaraemia infection in the community in rural Kanpur, Uttar Pradesh, India.
Kumar A; Sachan P; Bajpei A; Singh T
J Commun Dis; 2013; 45(1-2):33-40. PubMed ID: 25141552
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic filariasis in Andhra Pradesh Paper Mill Colony, Rajahmundry, India after nine rounds of MDA programme.
Mukhopadhyay AK
J Vector Borne Dis; 2010 Mar; 47(1):55-7. PubMed ID: 20231775
[No Abstract] [Full Text] [Related]
5. Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India.
Ramaiah KD; Vanamail P; Yuvaraj J; Das PK
Trans R Soc Trop Med Hyg; 2011 Aug; 105(8):431-7. PubMed ID: 21601901
[TBL] [Abstract][Full Text] [Related]
6. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
[TBL] [Abstract][Full Text] [Related]
7. Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations.
Sunish IP; Munirathinam A; Kalimuthu M; Ashok Kumar V; Tyagi BK
J Trop Pediatr; 2014 Jun; 60(3):245-8. PubMed ID: 24343822
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.
Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Thakur PA; Gupta A; Ingole NS; Lazdins-Helds JK
Parasitol Res; 2017 Oct; 116(10):2683-2694. PubMed ID: 28785847
[TBL] [Abstract][Full Text] [Related]
9. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
Sunish IP; Kalimuthu M; Rajendran R; Munirathinam A; Ashok Kumar V; Nagaraj J; Tyagi BK
Parasitol Int; 2015 Feb; 64(1):1-4. PubMed ID: 25205435
[TBL] [Abstract][Full Text] [Related]
10. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
Ramaiah KD; Das PK; Vanamail P; Pani SP
Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389
[TBL] [Abstract][Full Text] [Related]
11. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine.
Ramaiah KD; Vanamail P; Das PK
Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):250-5. PubMed ID: 16890256
[TBL] [Abstract][Full Text] [Related]
12. Assessment of microfilaremia in 'hotspots' of four lymphatic filariasis endemic districts of Nepal during post-MDA surveillance.
Mehta PK; Maharjan M
PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011932. PubMed ID: 38295107
[TBL] [Abstract][Full Text] [Related]
13. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
[TBL] [Abstract][Full Text] [Related]
14. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
Babu BV; Kar SK
Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
[TBL] [Abstract][Full Text] [Related]
15. Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India.
Bashar A; Nandekar SV; Shrivastava P; Singh RN; Srikrishnan P
J Vector Borne Dis; 2023; 60(3):307-316. PubMed ID: 37843242
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection.
Khan AM
Indian J Med Res; 2018 Jan; 147(1):7-10. PubMed ID: 29749354
[No Abstract] [Full Text] [Related]
17. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.
Ramzy RM; El Setouhy M; Helmy H; Ahmed ES; Abd Elaziz KM; Farid HA; Shannon WD; Weil GJ
Lancet; 2006 Mar; 367(9515):992-9. PubMed ID: 16564361
[TBL] [Abstract][Full Text] [Related]
18. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.
Stolk WA; Swaminathan S; van Oortmarssen GJ; Das PK; Habbema JD
J Infect Dis; 2003 Nov; 188(9):1371-81. PubMed ID: 14593597
[TBL] [Abstract][Full Text] [Related]
19. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
Nandha B; Krishnamoorthy K; Jambulingam P
Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Impact of Annual and Semiannual Mass Drug Administration on Lymphatic Filariasis Prevalence in Flores Island, Indonesia.
Supali T; Djuardi Y; Lomiga A; Nur Linda S; Iskandar E; Goss CW; Miller JP; Weil GJ; Fischer PU
Am J Trop Med Hyg; 2019 Feb; 100(2):336-343. PubMed ID: 30560772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
